Bioavailability Reboot PowerPoint PPT Presentation

presentation player overlay
About This Presentation
Transcript and Presenter's Notes

Title: Bioavailability Reboot


1
(No Transcript)
2
Maxicuma is clinically studied to deliver J72
foLds
more free curcumin in the Human Pharmacokinetic
study
compared to standard curcumin 957
(micronized) Published in the Journal of Current
Research of Complementary and Alternative
Medicine 7 191. Get access of the full published
version hei e In an open-label, non-randomized,
two-perioct, single dose, twD-group crossover
study with the total duration of 21 days
(including T4 days washout period), on healthy
adults, under fasting conditions, Maxicuma
exhibitecl (in comparison with standard curcumin
3
Maxicuma vis Micronized
O
Curcumin
Free Curcumin
More Free Curcumin
Free DMC
Free BDMC
Maxicuma
Micronized Curcumin 95
Higher Total AUCt
4
The free curcumin component in blood plasma is
responsible for biological action. Research
suggests that the level of efficacy is best
determined by the levels of unmetabofized free
curcumin in the ingredient. Inactive
Constituents Excreted rapidly, producing little
or no biological activity.
5
Curcumin Bioavailability - The GOLD Standards
  • Most of the new generation curcumin ingredients
    claim higher bioavailability. as tney reflect the
    total curcuminoid levels without specifying the
    metabolites and free curcumin funmetabolized
    major bioactive) in their product, misleading the
    formulators with tall claims.
  • The right way of measuring and reporting every
    curcuminoid compound in its free form, as well as
    its respective metabolite, is the pold standard
    of measuring the bioavailability of turmeric
    ingredients, as performed in studies
    investigating Maxicuma.

6
Bibtiography
  • MarieL CaLderón-Oliver et at., 2022. The Role of
    Microencapsulation in Food Application.
  • Sidney J. Stohsel af., 2019. The fallacy of
    enzymatic hydrolysis for the determination of
    bioactive curcumin in plasma samples as an
    indication of bioavailability A comparative
    study.
  • Kednapa Thavorn et aL., 2023. A systematic review
    of the efficacy and safety of turmeric in the
    treatment of digestive disorders.

Get in touch
Write a Comment
User Comments (0)
About PowerShow.com